Calls
1
Andrew Dudum
CEO, Hims & Hers
Win Rate
100.0%
return
+21.7%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Aug 18
$27.73
+21.7%
Peptides are the next big growth area for Hims & Hers; the company acquired a Menlo Park peptide manufacturing plant and may be the only US company able to bring American-made peptides from raw ingredients to patients, with plans to launch if FDA moves peptides to category one and with clinical oversight plus home blood testing.
GLP-1 / Obesity
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Andrew Dudum has 1 trade ideas tracked on Buzzberg across 1 tickers since August 2026. Most covered: HIMS.
